Other languages CONMED Corporation

Equities

CNMD

US2074101013

Market Closed - Nyse Other stock markets 04:00:02 2024-04-26 pm EDT			5-day change	1st Jan Change
65.78 ^USD	+6.27%		-9.44%	-39.93%

Apr. 25	Wells Fargo Adjusts Price Target on CONMED to $77 From $98, Maintains Equalweight Rating	MT
Apr. 25	Needham Lowers Price Target on CONMED to $107 From $129, Notes Slight Guidance Cut Due to Currency, Keeps Buy Rating	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CONMED Corporation Promotes Patrick Beyer to Chief Operating Officer	Apr. 24
CONMED Corporation Revises Earnings Guidance for the Full Year 2024	Apr. 24
CONMED Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 24
CONMED Corporation Announces Not Stand for Re-Election of Jerome Lande as Director	Apr. 08
CONMED Corporation Declares Quarterly Cash Dividend, Payable on April 5, 2024	Feb. 27
Sector Update: Health Care Stocks Rise in Late Afternoon	Feb. 01
CONMED Shares Fall After Q4 Results Trail Analyst Estimates	Feb. 01
CONMED Q4 Adjusted Earnings, Net Sales Rise; Sets 2024 Outlook; Shares Drop	Jan. 31
CONMED Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Jan. 31
CONMED Corporation Provides Financial Guidance for the Full Year 2024	Jan. 31
CONMED Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Jan. 31
Conmed Insider Sold Shares Worth $252,833, According to a Recent SEC Filing	Dec. 06
CONMED Corporation Announces Quarterly Cash Dividend, Payable on January 5, 2024	Dec. 05
Conmed Insider Sold Shares Worth $122,874, According to a Recent SEC Filing	Nov. 09
Conmed's Q3 Adjusted Earnings, Sales Rise; Raises Low End of 2023 Outlook Range	23-10-26
CONMED Corporation Updates Third Quarter Guidance for 2023	23-10-25
CONMED Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-25
CONMED Corporation Announces Quarterly Cash Dividend, Payable on October 5, 2023	23-08-10
Conmed Corporation Provides Revenue Guidance for the Third Quarter 2023	23-07-26
CONMED Corporation Revises Earnings Guidance for the Full Year 2023	23-07-26

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages CONMED Corporation

Equities

CNMD

US2074101013

Other languages

Filters